INDIAN CANCER GENETICS CONFERENCE – ICGC 2013
In collaboration with the Indo-UK Genetic Education Forum
Advanced Centre for Treatment Research & Education in Cancer (ACTREC)
Tata Memorial Centre, Kharghar, Navi Mumbai, India • 23-25 January, 2013
somatic genetic alteration, 5% of cancer cases have germline genetic alterations making it a Mendelian hereditary condition. Of the
One million new cancer cases in India, it is estimated that 50,000 are due to Mendelian inheritance. Research over the last 2 decades
has established that germline mutations in genes such as BRCA1/2, TP53, APC, Mismatch Repair Genes, Retinoblastoma etc. are
responsible for speci c inherited cancer syndromes. Molecular DNA analysis and genetic testing in research and health care setting
is now being increasingly used and guiding cancer control and prevention strategies in this very high-risk group. The eld of Cancer
Genetics is growing rapidly in India with increasing number of molecular diagnostic labs and research labs entering into the arena.
The Cancer Genetics Unit and the ICMR Centre for Advanced Research in Cancer Genetics at ACTREC and Tata Memorial Hospital
serves as the apex comprehensive cancer genetic referral centre in South Asia catering to oncologists & families from all over the
region. ACTREC is one of the two leading Indian centres in the International Cancer Genome Consortium (ICGC) project.
*Registration Fee Up to Up to From
31.12.12 15.01.13 16.01.13
Conference 2500 3000 3500
Conference &Workshop 3500 4000 4500
Conference, Workshop & 1 week training 6500 8000 9000
REF: http://www.biotecnika.org/external?url=http://www.actrec.gov.in/data%20files/2012/Brochure-ICGC2013.pdf
No comments:
Post a Comment